HomeCompareRMD vs AVY

RMD vs AVY: Dividend Comparison 2026

RMD yields 1.06% · AVY yields 2.24%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVY wins by $232.8K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
AVY
AVY
● Live price
2.24%
Share price
$168.15
Annual div
$3.76
5Y div CAGR
57.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$264.5K
Annual income
$138,265.18
Full AVY calculator →

Portfolio growth — RMD vs AVY

📍 AVY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDAVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + AVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
AVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
AVY
Annual income on $10K today (after 15% tax)
$190.07/yr
After 10yr DRIP, annual income (after tax)
$117,525.40/yr
At 15% tax rate, AVY beats the other by $114,730.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + AVY for your $10,000?

RMD: 50%AVY: 50%
100% AVY50/50100% RMD
Portfolio after 10yr
$148.1K
Annual income
$70,776.71/yr
Blended yield
47.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AVY right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
AVY
Analyst Ratings
13
Buy
5
Hold
Consensus: Buy
Price Target
$221.00
+31.4% upside vs current
Range: $200.00 — $234.00
Altman Z
3.5
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
AVY buys
0
No recent congressional trades found for RMD or AVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDAVY
Forward yield1.06%2.24%
Annual dividend / share$2.33$3.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%57.9%
Portfolio after 10y$31.7K$264.5K
Annual income after 10y$3,288.25$138,265.18
Total dividends collected$10.4K$231.2K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$295.88$221.00

Year-by-year: RMD vs AVY ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrAVY PortfolioAVY Income/yrGap
1← crossover$10,844$143.91$11,053$353.08$209.00AVY
2$11,801$198.21$12,403$575.91$602.00AVY
3$12,901$273.96$14,225$953.64$1.3KAVY
4$14,185$380.39$16,834$1,614.01$2.6KAVY
5$15,709$531.20$20,831$2,818.78$5.1KAVY
6$17,556$747.16$27,437$5,147.36$9.9KAVY
7$19,845$1,060.53$39,362$10,004.60$19.5KAVY
8$22,757$1,522.63$63,298$21,180.73$40.5KAVY
9$26,567$2,217.64$117,993$50,263.39$91.4KAVY
10$31,715$3,288.25$264,517$138,265.18$232.8KAVY

RMD vs AVY: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

AVYMaterials

Avery Dennison Corporation manufactures and markets pressure-sensitive materials and products in the United States, Europe, Asia, Latin America, and internationally. The company's Label and Graphic Materials segment offers pressure-sensitive label and packaging materials; and graphics and reflective products under the Fasson, JAC, Avery Dennison, and Mactac brands, as well as durable cast and reflective films. It provides its products to the home and personal care, beer and beverage, durables, pharmaceutical, wine and spirits, and food market segments; architectural, commercial sign, digital printing, and other related market segments; construction, automotive, and fleet transportation market segments, as well as traffic and safety applications; and sign shops, commercial printers, and designers. The company's Retail Branding and Information Solutions segment designs, manufactures, and sells brand embellishments, graphic tickets, tags and labels, and sustainable packaging solutions, as well as offers creative services; radio-frequency identification products; visibility and loss prevention solutions; price ticketing and marking solutions; care, content, and country of origin compliance solutions; and brand protection and security solutions. It serves retailers, brand owners, apparel manufacturers, distributors, and industrial customers. The company's Industrial and Healthcare Materials segment offers tapes; pressure-sensitive adhesive based materials and converted products; medical fasteners; and performance polymers under the Fasson, Avery Dennison, and Yongle brands. It serves automotive, electronics, building and construction, general industrial, personal care, and medical markets. The company was formerly known as Avery International Corporation and changed its name to Avery Dennison Corporation in 1990. Avery Dennison Corporation was founded in 1935 and is headquartered in Glendale, California.

Full AVY Calculator →
📬

Get this RMD vs AVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.